Darya-Varia Executive and Leadership Team

Celso Lim, the Chief Financial Officer at Darya-Varia, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the Gunung Putri and Citeureup plants, the Chief Financial Officer ensures that resource distribution aligns with the production of soft gelatin capsules, sterile injections, and medicinal plasters. This leadership role involves managing complex budgetary requirements for technology transfers and pilot trials while maintaining strict adherence to international ISO standards. By optimizing procurement processes for raw materials and packaging, Celso Lim directly impacts the profitability of the Export and Toll Manufacturing business segments. Furthermore, the Chief Financial Officer monitors the financial implications of the halal guarantee system across all facilities. Through precise fiscal oversight, Lim secures the long-term economic stability necessary for the company to continue providing high-quality health facilities throughout the Indonesian market and beyond.

Ian Kloer, the President & Director at Darya-Varia, executes the overarching corporate strategy and operational vision. Overseeing the integration of management systems at the Gunung Putri and Citeureup plants, the President & Director ensures that all manufacturing processes meet rigorous ISO 9001, 14001, 45001, and 22000 certifications. This leadership role involves driving the expansion of the Toll Manufacturing business through strategic collaborations with partners like PT Medifarma Laboratories. By championing the mission of building a healthier Indonesia, Ian Kloer coordinates the development of high-quality finished goods ranging from tablets to ointments. Kloer maintains constant alignment with the Board to ensure that all production facilities uphold the highest safety and halal standards. Ultimately, the President & Director fosters innovation in lab trials and stability studies, positioning the company as a trusted leader in the domestic and international pharmaceutical landscape.

Clinton Hess, the President & Commissioner at Darya-Varia, provides high-level governance and strategic guidance to the board. Overseeing the alignment of corporate objectives with the long-term mission of improving public health, the President & Commissioner ensures that the company maintains its competitive edge in the pharmaceutical manufacturing sector. This leadership role involves evaluating the performance of the Gunung Putri and Citeureup plants while monitoring the efficacy of the Integrated Management System. By facilitating communication between the board and executive management, Clinton Hess supports the expansion of export capabilities and the successful execution of technology transfer initiatives. The President & Commissioner also reviews the impact of the halal guarantee system on market reach and consumer trust. Through consistent oversight of operational standards, Hess drives the strategic direction required to sustain the company's growth and commitment to quality health solutions.

Sancoyo Antarikso, the Independent Commissioner at Darya-Varia, monitors corporate compliance and ensures the integrity of internal governance frameworks. Overseeing the adherence to SNI ISO/IEC 17025:2017 and other regulatory standards, the Independent Commissioner provides objective analysis of the operational performance at the Citeureup and Gunung Putri plants. This leadership role involves evaluating the effectiveness of the halal guarantee system and the quality control protocols applied to sterile injections and solid preparations. By providing impartial oversight, Sancoyo Antarikso assists the board in mitigating risks associated with raw material procurement and international export operations. The Independent Commissioner also reviews the strategic outcomes of the Toll Manufacturing business to ensure alignment with the company's core mission. Through diligent scrutiny of management practices, Antarikso upholds the transparency and ethical standards essential for maintaining the trust of local business partners and the broader Indonesian public.